Oxomemazine Sans Sucre Cristers

Oxomemazine, the active ingredient in Oxomemazine Sans Sucre Cristers, is a first‑generation antihistamine presented as a tablet for oral use. It is employed to relieve allergic symptoms such as itching, rash and runny nose in children and adults. GNH USA supplies Oxomemazine Sans Sucre Cristers as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxomemazine is a first‑generation antihistamine that acts on histamine‑H1 receptors to alleviate allergic conditions. - Allergic rhinitis: reduces sneezing, nasal congestion and itching. - Urticaria (hives): diminishes wheal formation and pruritus. - Pruritus of the skin: provides relief from generalized itching associated with allergic reactions.

Oxomemazine may cause a range of adverse reactions, most of which are dose‑dependent and reversible.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dry mouth: reduced salivation leading to a sticky sensation. - Dizziness: light‑headed feeling, especially when standing quickly. - Blurred vision: temporary difficulty focusing. - Constipation: slowed gastrointestinal motility.

Serious or Rare Side Effects: - Cardiac arrhythmias: irregular heart rhythm that may require medical attention. - Severe allergic reaction: rash, swelling, or difficulty breathing. - Hepatotoxicity: signs of liver injury such as jaundice. - Extrapyramidal symptoms: involuntary muscle movements or tremor. - Hematologic abnormalities: unexplained bruising or low blood counts.

When prescribing Oxomemazine, clinicians should consider several safety aspects. - Pregnancy: avoid use unless the benefit outweighs the risk; limited data are available. - Breastfeeding: may pass into milk; weigh benefits against potential infant effects. - Elderly patients: start with lower doses due to increased sensitivity to sedation. - Concomitant CNS depressants: may enhance drowsiness and impair coordination. - Driving or operating machinery: advise patients to assess tolerance before engaging in such activities. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Oxomemazine can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid):\n- Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis and excessive sedation. - Other antihistamines: additive sedation and anticholinergic effects. - CNS depressants (e.g., benzodiazepines, opioids): heightened drowsiness and respiratory depression.

Moderate Interactions (Monitor Closely): - Alcohol: may increase sedation and impair judgment. - Anticholinergic drugs: enhanced dry‑mouth and constipation. - CYP450 inhibitors (e.g., erythromycin): possible increase in oxox‑​​   - CYP